Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Capasso, Immacolata ^a   Esposito, Emanuela ^a   Pentimalli, Francesca ^a   Montella, Maurizio ^a   Crispo, Anna ^a   Maurea, Nicola ^a   D'Aiuto, Massimiliano ^a   Fucito, Alfredo ^a   Grimaldi, Maria ^a   Cavalcanti, Ernesta ^a   Esposito, Giuseppe ^a   Brillante, Giuseppe ^a   Lodato, Sergio ^a   Pedicini, Tonino ^a   D'Aiuto, Giuseppe ^a   Ciliberto, Gennaro ^a   Giordano, Antonio ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Temple University   (United States)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Breast cancer; HOMA IR; Insulin resistance; Metabolic syndrome; Postmenopausal

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SCREENING; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HOMEOSTASIS MODEL ASSESSMENT SCORE; HUMAN; HYPERINSULINEMIA; HYPOTHESIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; POSTMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; ITALY; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84874930452     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-14     Document Type: Article

References (19)

1. Metabolic syndrome affects breast-cancer risk in postmenopausal women national cancer institute of Naples experience. Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, De Marco M, Cancer Biology & Therapy 2010 10:12 1 4 23550278
2. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Nutr Metab Cardiovasc Dis 2010 20 1 41 8 Epub 2009 Apr 10 10.1016/j.numecd.2009.02.006 19361966
3. Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, Diabetes 2004 53 2087 2094 10.2337/diabetes.53.8.2087 15277390 (Pubitemid 38970759)
4. Ervin RB, Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: united states, 2003-2006. National health statistics reports; no 13 Hyattsville, MD: National Center for Health Statistics 2009 19634296
5. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Doyle SL, Donohoe CL, Lysaght J, Reynolds JV, Proc Nutr Soc 2012 71 (1 181 189 Epub 2011 Nov 3 22051112
6. Molecular mechanisms of cancer development in obesity. Khandekar MJ, Cohen P, Spiegelman BM, Nat Rev Cancer 2011 11 12 886 895 10.1038/nrc3174 22113164
7. Diabetes and cancer. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R, Endocr Relat Cancer 2009 16 4 1103 1123 Epub 2009 Jul 20 10.1677/ERC-09-0087 19620249
8. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Lancet 1998 351 1393 10.1016/S0140-6736(97)10384-1 9593409 (Pubitemid 28209997)
9. Plasma insulin, IGF-I and breast cancer. Kaaks R, Gynecol Obstet Fertil 2001 29 185 191 10.1016/S1297-9589(00)00047-3 11300043 (Pubitemid 32239809)
10. Elevated insulin receptor content in human breast cancer. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, J Clin Invest 1990 86 5 1503 1510 10.1172/JCI114868 2243127 (Pubitemid 20372597)
11. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' health study. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Diabetes Care 2003 26 1752 1758 10.2337/diacare.26.6.1752 12766105 (Pubitemid 36929115)
12. Adipokines, insulin resistance, metabolic syndrome,and breast cancer recurrence: a cohort study. Oh SW, Park CY, Lee ES, Yoon YS, Lee ES, Park SS, Kim Y, Sung NJ, Yun YH, Lee KS, Kang HS, Kwon Y, Ro J, Breast Cancer Research 2011 13 34 10.1186/bcr2856 21450081
13. Standards of medical care in diabetes- 2012. American Diabetes Association, Diabetes Care 2012 35 1 11 63 10.2337/dc12-s011 22187469
14. "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 7 412 9 10.1007/BF00280883 3899825 (Pubitemid 15018832)
15. Upper abdominal obesity, insulin resistance and breast cancer risk. Stoll BA, Int J Obes Relat Metab Disord 2002 26 6 747 53 12037643 (Pubitemid 34620865)
16. Dietary fat and the risk of breast cancer: a prospective study of 25,892 Norwegian women. Gaard M, Tretli S, Loken EB, Int J Cancer 1995 63 13 7 10.1002/ijc.2910630104 7558440
17. Waisthip ratio and breast cancer risk in urbanized Nigerian women. Adebamowo CA, Ogundiran TO, Adenipekun AA, Oyesegun RA, Campbell OB, Akang EE, Breast Cancer Res 2003 5 18 24 10.1186/bcr677
18. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Stoll BA, Eur J Clin Nutr 1999 53 83 7 10.1038/sj.ejcn.1600700 10099938 (Pubitemid 29082524)
19. Case control study of anthropometric measures and breast cancer risk. Friedenreich CM, Courneya KS, Bryant HE, Int J Cancer 2002 99 445 52 10.1002/ijc.10389 11992416 (Pubitemid 34495861)